Chi Advisors LLC Pliant Therapeutics, Inc. Transaction History

Chi Advisors LLC

$203 Million
Q3 2023

A detailed history of Chi Advisors LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Chi Advisors LLC holds 3,014,199 shares of PLRX stock, worth $34.8 Million. This represents 25.76% of its overall portfolio holdings.

Number of Shares

3,014,199

Previous 3,117,017 3.3%

Holding current value

$34.8 Million

Previous $56.5 Million 7.46%

% of portfolio

25.76%

Previous 21.23%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$14.58 - $20.15 $1.5 Million - $2.07 Million	-102,818 Reduced 3.3%	3,014,199 $52.3 Million
Q2 2023 Aug 11, 2023	BUY	$18.12 - $30.56 $2.09 Million - $3.52 Million	115,182 Added 3.84%	3,117,017 $56.5 Million
Q1 2023 May 11, 2023	SELL	$18.73 - $36.26 $3.15 Million - $6.09 Million	-168,057 Reduced 5.3%	3,001,835 $79.8 Million
Q4 2022 Feb 13, 2023	SELL	$17.0 - $25.43 $4.08 Million - $6.1 Million	-239,866 Reduced 7.03%	3,169,892 $61.3 Million
Q3 2022 Nov 09, 2022	BUY	$7.67 - $24.23 $2.32 Million - $7.34 Million	302,951 Added 9.75%	3,409,758 $71.2 Million
Q2 2022 Aug 12, 2022	BUY	$4.11 - $8.75 $1.85 Million - $3.93 Million	449,350 Added 16.91%	3,106,807 $24.9 Million
Q1 2022 May 16, 2022	BUY	$7.01 - $14.1 $616,725 - $1.24 Million	87,978 Added 3.42%	2,657,457 $18.6 Million
Q4 2021 Feb 11, 2022	BUY	$12.27 - $18.26 $1.04 Million - $1.55 Million	84,755 Added 3.41%	2,569,479 $34.7 Million
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $1.93 Million - $3.39 Million	116,836 Added 4.93%	2,484,724 $41.9 Million
Q2 2021 Aug 11, 2021	BUY	$28.05 - $37.69 $1.21 Million - $1.62 Million	43,093 Added 1.85%	2,367,888 $69 Million
Q1 2021 May 14, 2021	SELL	$24.52 - $40.23 $735,698 - $1.21 Million	-30,004 Reduced 1.27%	2,324,795 $91.4 Million
Q4 2020 Feb 12, 2021	BUY	$19.89 - $32.99 $49,884 - $82,738	2,508 Added 0.11%	2,354,799 $53.5 Million
Q3 2020 Nov 12, 2020	BUY	$21.54 - $29.53 $997,237 - $1.37 Million	46,297 Added 2.01%	2,352,291 $53.3 Million
Q2 2020 Aug 12, 2020	BUY	$21.3 - $35.26 $49.1 Million - $81.3 Million	2,305,994 New	2,305,994 $74.9 Million

Others Institutions Holding PLRX

# of Institutions

158

Shares Held

63.8M

Call Options Held

481K

Put Options Held

105K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $561M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chi Advisors LLC with notifications on news.

Account